Swedish Orphan Biovitrum Balance Sheet Health
Financial Health criteria checks 3/6
Swedish Orphan Biovitrum has a total shareholder equity of SEK37.1B and total debt of SEK17.5B, which brings its debt-to-equity ratio to 47.1%. Its total assets and total liabilities are SEK72.2B and SEK35.1B respectively. Swedish Orphan Biovitrum's EBIT is SEK6.1B making its interest coverage ratio 4.5. It has cash and short-term investments of SEK594.0M.
Key information
47.1%
Debt to equity ratio
SEK 17.47b
Debt
Interest coverage ratio | 4.5x |
Cash | SEK 594.00m |
Equity | SEK 37.11b |
Total liabilities | SEK 35.09b |
Total assets | SEK 72.20b |
Recent financial health updates
No updates
Recent updates
Financial Position Analysis
Short Term Liabilities: B6E0's short term assets (SEK12.6B) do not cover its short term liabilities (SEK13.9B).
Long Term Liabilities: B6E0's short term assets (SEK12.6B) do not cover its long term liabilities (SEK21.2B).
Debt to Equity History and Analysis
Debt Level: B6E0's net debt to equity ratio (45.5%) is considered high.
Reducing Debt: B6E0's debt to equity ratio has reduced from 55.4% to 47.1% over the past 5 years.
Debt Coverage: B6E0's debt is well covered by operating cash flow (38.1%).
Interest Coverage: B6E0's interest payments on its debt are well covered by EBIT (4.5x coverage).